Correlation Between SILICON LABORATOR and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SILICON LABORATOR and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SILICON LABORATOR and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SILICON LABORATOR and AstraZeneca PLC, you can compare the effects of market volatilities on SILICON LABORATOR and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SILICON LABORATOR with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of SILICON LABORATOR and AstraZeneca PLC.

Diversification Opportunities for SILICON LABORATOR and AstraZeneca PLC

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between SILICON and AstraZeneca is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding SILICON LABORATOR and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and SILICON LABORATOR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SILICON LABORATOR are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of SILICON LABORATOR i.e., SILICON LABORATOR and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between SILICON LABORATOR and AstraZeneca PLC

Assuming the 90 days trading horizon SILICON LABORATOR is expected to generate 1.34 times more return on investment than AstraZeneca PLC. However, SILICON LABORATOR is 1.34 times more volatile than AstraZeneca PLC. It trades about 0.14 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about -0.06 per unit of risk. If you would invest  10,200  in SILICON LABORATOR on October 10, 2024 and sell it today you would earn a total of  2,300  from holding SILICON LABORATOR or generate 22.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

SILICON LABORATOR  vs.  AstraZeneca PLC

 Performance 
       Timeline  
SILICON LABORATOR 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SILICON LABORATOR are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, SILICON LABORATOR unveiled solid returns over the last few months and may actually be approaching a breakup point.
AstraZeneca PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

SILICON LABORATOR and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SILICON LABORATOR and AstraZeneca PLC

The main advantage of trading using opposite SILICON LABORATOR and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SILICON LABORATOR position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind SILICON LABORATOR and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences